EMEA-001384-PIP01-12
Key facts
| Active substance |
octenidine dihydrochloride
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0360/2016
|
| PIP number |
EMEA-001384-PIP01-12
|
| Pharmaceutical form(s) |
Cutaneous solution
|
| Condition(s) / indication(s) |
Skin disinfection
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
Schülke & Mayr GmbH
Germany
E-mail: mail@schuelke.com Tel.: +49 40521000 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|